Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells.
Journal
HemaSphere
ISSN: 2572-9241
Titre abrégé: Hemasphere
Pays: United States
ID NLM: 101740619
Informations de publication
Date de publication:
Oct 2024
Oct 2024
Historique:
received:
16
04
2024
revised:
12
07
2024
accepted:
31
07
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
9
10
2024
Statut:
epublish
Résumé
In multiple myeloma, as in B-cell malignancies, mono- and especially bi-allelic
Identifiants
pubmed: 39380841
doi: 10.1002/hem3.70016
pii: HEM370016
pmc: PMC11460984
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e70016Informations de copyright
© 2024 The Author(s). HemaSphere published by John Wiley & Sons Ltd on behalf of European Hematology Association.
Déclaration de conflit d'intérêts
Hélène Asnagli, Andrew Parker, and Philip Beer are employees of Step Pharma. The remaining authors declare no conflict of interest.